Appendix 1: Joint Working Case Studies


AstraZeneca and Leeds Teaching Hospitals NHS Trust collaborated on the ‘Re-engineering the Post-Myocardial Infarction Medicines Optimisation Pathway’ Joint Working project. The project provided a comprehensive medicines review for patients with cardiovascular disease who have recently suffered a myocardial infarction (MI) and assessed if this intervention improved patient outcomes. The project adopted a patient-centred approach and shared decision-making strategies to enable the establishment of true medicines partnership and has been NICE Quality Assured as an example of Shared Learning.


Bayer’s ‘Don’t Wait to Anticoagulate’ collaboration with West of England AHSN delivered a project aimed at helping prevent strokes amongst patients with AF by optimising medicines management in primary care. 13 strokes have been avoided through joint working, reducing the overall burden of care to the NHS and saving significant sums of money.


Janssen UK, Welsh Government, NHS Wales and Myeloma UK have partnered to co-create and implement an All Wales Haematological Malignancy Data Solution, which will capture Real World Evidence for improving patient outcomes and facilitating a value-based healthcare environment.


MSD worked with Aylesbury Vale and Chiltern CCGs to improve the quality of their diabetes service, by looking at innovative ways to address population health challenges and to standardise the approach across all the practices involved. The programme aimed to better support patients to manage their diabetes by having a greater understanding of their condition and the treatment options available to them, thus supporting self-care, leading to improved management and quality of life.


Novartis and Chelsea and Westminster Hospital NHS Foundation Trust’s collaboration in heart failure (HF) aims to improve detection and treatment of HF in primary and secondary care as well as educate patients on how to manage their condition at home. The expected outcome of the project is optimisation of care for HF patients irrespective of the care setting.

Last modified: 20 September 2023

Last reviewed: 20 September 2023